Blockchain Registration Transaction Record

Tonix Scores Major Medicare Deal for TONMYA, Covering 145M Lives

Tonix Pharmaceuticals secures Medicare agreement for TONMYA, covering 145M lives. First new fibromyalgia treatment in 15 years expands access to non-opioid option.

This news matters because it expands access to a non-opioid treatment for fibromyalgia, a chronic pain condition affecting millions of Americans. With Medicare and commercial coverage reaching nearly half the U.S. market, patients now have a new, potentially safer option for managing their symptoms. Tonix's move to increase its sales force signals confidence in TONMYA's adoption, offering hope to those who have had limited treatment choices for over a decade. The broader coverage could reduce reliance on opioids and improve quality of life for many fibromyalgia sufferers.